Efficacy of Fibromyalgia Treatments in Primary vs. Specialized Care
Author Information
Author(s): Garcia-Campayo Javier, Magdalena Jesus, Magallón Rosa, Fernández-García Esther, Salas Montserrat, Andrés Eva
Primary Institution: Miguel Servet Hospital, University of Zaragoza, Zaragoza, Spain
Hypothesis
Does the level of care (primary vs. specialized) affect the efficacy of fibromyalgia treatments?
Conclusion
Treating fibromyalgia in specialized care offers no clear advantages over primary care.
Supporting Evidence
- The study included 33 randomized controlled trials assessing 120 treatment interventions.
- 57.8% of patients were treated in primary care and 42.2% in specialized care.
- The mean effect size of treatment efficacy was 0.49, indicating moderate effectiveness.
Takeaway
This study found that doctors in regular clinics can help fibromyalgia patients just as well as specialists in hospitals.
Methodology
A systematic review and meta-analysis of randomized controlled trials comparing treatments for fibromyalgia in primary and specialized care.
Potential Biases
Potential bias due to the subjective nature of treatment allocation and the variability in study quality.
Limitations
Heterogeneity of the disorder, variability of outcomes, and subjective treatment allocation.
Participant Demographics
Mostly middle-aged women with fibromyalgia for 6 to 10 years.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI = 0.39 to 0.58
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website